Mineralocorticoid and Glucocorticoid Receptors Stimulate Epithelial Sodium Channel Activity in a Mouse Model of Cushing Syndrome

被引:56
作者
Bailey, Matthew A. [1 ]
Mullins, John J. [1 ]
Kenyon, Christopher J. [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Mol Physiol Grp, Edinburgh EH16 4TJ, Midlothian, Scotland
基金
英国惠康基金; 英国医学研究理事会;
关键词
renal clearance; amiloride; 11 beta-hydroxysteroid dehydrogenase; tubular sodium reabsorption; furosemide; ADRENOCORTICOTROPIN-INDUCED HYPERTENSION; II BARTTERS-SYNDROME; BLOOD-PRESSURE; POTASSIUM EXCRETION; ADRENAL-STEROIDS; ACTH; TRANSPORT; CORTISOL; RAT; EXPRESSION;
D O I
10.1161/HYPERTENSIONAHA.109.134973
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Experiments in Cushing patients and healthy control subjects receiving adrenocorticotropic hormone (ACTH) indicate that transient renal sodium retention may contribute to the generation of hypertension. Here we have investigated the effect of chronic ACTH infusion on renal sodium handling in adult male C57BL/6J mice using selective antagonists to dissect mineralocorticoid and glucocorticoid receptor-mediated pathways. Mice were infused via osmotic minipump with ACTH (2.5 mu g/d) or saline for 2 weeks before being anesthetized for renal function experiments. ACTH caused an increase in blood pressure and a reduction in fractional sodium excretion associated with enhanced activity of the epithelial sodium channel. Given separately, spironolactone and RU38486 blunted the pressor response to ACTH and the increased epithelial sodium channel activity; combined mineralocorticoid and glucocorticoid receptor blockade was required to resolve the response to ACTH excess. Dietary sodium depletion also prevented ACTH-induced hypertension. The effect of increased sodium reabsorption in the distal nephron is offset by downregulation of Na-K-Cl cotransport in the loop of Henle. Sodium excretion is normalized chronically, but blood pressure remains high; acute blockade of V1 receptors and alpha 1 adrenoceptors in combination restored blood pressure to control values. In summary, ACTH excess promotes renal sodium reabsorption, contributing to the increased blood pressure; both glucocorticoid and mineralocorticoid receptor pathways are involved. These data are relevant to conditions associated with overactivity of the hypothalamic-pituitary-adrenal axis, such as obesity and chronic stress. (Hypertension. 2009; 54: 890-896.)
引用
收藏
页码:890 / 896
页数:7
相关论文
共 49 条
[11]   Structural and functional changes in the kidneys of high-fat diet-induced obese mice [J].
Deji, Naoko ;
Kume, Shinji ;
Araki, Shin-ichi ;
Soumura, Mariko ;
Sugimoto, Toshiro ;
Isshiki, Keiji ;
Chin-Kanasaki, Masami ;
Sakaguchi, Masayoshi ;
Koya, Daisuke ;
Haneda, Masakazu ;
Kashiwagi, Atsunori ;
Uzu, Takashi .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2009, 296 (01) :F118-F126
[12]   Human kidney 11 beta-hydroxysteroid dehydrogenase: Regulation by adrenocorticotropin? [J].
Diederich, S ;
Quinkler, M ;
Miller, K ;
Heilmann, P ;
Schoneshofer, M ;
Oelkers, W .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1996, 134 (03) :301-307
[13]   CORTICOSTEROIDS DECREASE GLOMERULAR ANGIOTENSIN RECEPTORS [J].
DOUGLAS, JG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (03) :F453-F457
[14]   Altered expression of renal NHE3, TSC, BSC-1, and ENaC subunits in potassium-depleted rats [J].
Elkjær, ML ;
Kwon, TH ;
Wang, WD ;
Nielsen, J ;
Knepper, MA ;
Frokiær, J ;
Nielsen, S .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 283 (06) :F1376-F1388
[15]   Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney:: Hormonal control [J].
Féraille, E ;
Doucet, A .
PHYSIOLOGICAL REVIEWS, 2001, 81 (01) :345-418
[16]   Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease [J].
Ferrari, P .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 17 (04) :575-589
[17]   VITAMIN-D METABOLITES AND PARATHYROID-HORMONE IN CUSHINGS-SYNDROME - RELATIONSHIP TO CALCIUM AND PHOSPHORUS HOMEOSTASIS [J].
FINDLING, JW ;
ADAMS, ND ;
LEMANN, J ;
GRAY, RW ;
THOMAS, CJ ;
TYRRELL, JB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (05) :1039-1044
[18]   Vasopressin V1A receptor antagonism does not reverse adrenocorticotrophin-induced hypertension in the rat [J].
Fraser, TB ;
Turner, SW ;
Wen, C ;
Li, M ;
Burrell, LM ;
Whitworth, JA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (11) :866-870
[19]   MINERALOCORTICOID ACTION - TARGET TISSUE-SPECIFICITY IS ENZYME, NOT RECEPTOR, MEDIATED [J].
FUNDER, JW ;
PEARCE, PT ;
SMITH, R ;
SMITH, AI .
SCIENCE, 1988, 242 (4878) :583-585
[20]   Mineralocorticoid versus glucocorticoid receptor occupancy mediating aldosterone-stimulated sodium transport in a novel renal cell line [J].
Gaeggeler, HP ;
Gonzalez-Rodriguez, E ;
Jaeger, NF ;
Loffing-Cueni, D ;
Norregaard, R ;
Loffing, J ;
Horisberger, JD ;
Rossier, BC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :878-891